Community-Acquired Pneumonia

Assess oxygenation, respiratory work, blood pressure, mental status, and need for ventilatory or vasopressor support at presentation. CAP severity tools identify lower-risk patients suitable for ambulatory treatment, but they should not override an immediate requirement for invasive respiratory or vasopressor support. journal chestnetjournal chestnetProcalcitonin in Severe Community-Acquired Pneumonia - CHEST

Use a two-step disposition approach: first decide whether hospitalization is needed, then determine ward versus ICU-level care. Clinical judgment is a required modifier because prognostic scores incompletely capture social support, baseline function, and rapidly evolving physiologic failure. Wolters KluwerWolters KluwerGuidelines for diagnosis and management of community- ...

Establish CAP when a new pulmonary infiltrate is present on chest imaging together with compatible acute lower-respiratory symptoms or findings. In hospitalized patients with suspected CAP, order chest radiography to confirm or exclude the diagnosis. BMJ+1BMJCommunity-acquired pneumonia in adults (non Covid-19) - Symptoms, diagnosis and treatment | BMJ Best Practice USNatureImpact of antibiotic changes on hospital stay and treatment duration in community-acquired pneumonia | Scientific Reports

When a portable radiograph is equivocal, technically limited, or discordant with the clinical examination, use point-of-care lung ultrasound as an adjunct. A meta-analysis reported pooled sensitivity of 88% and specificity of 86% for adult pneumonia, with higher sensitivity than chest radiography in the included comparison. Wolters KluwerWolters KluwerLung ultrasound for the diagnosis of pneumonia in adults: A ... : Medicine

Do not use CRP or procalcitonin as routine standalone diagnostic tests for CAP. Interpret inflammatory biomarkers only alongside the clinical syndrome and imaging, where they may contribute to severity assessment rather than establish the diagnosis. Wolters Kluwer+1Wolters KluwerRole of biomarkers in community-acquired pneumonia... : Journal of Acute DiseaseWolters KluwerGuidelines for diagnosis and management of community- ...

Calculate the PSI when selecting outpatient versus inpatient care. PSI uses demographic characteristics, comorbidities, examination findings, laboratory values, and imaging data to stratify mortality risk; the 2019 ATS/IDSA approach recommends PSI with clinical judgment. Wolters KluwerWolters KluwerThe Saudi Thoracic Society evidence‐based guidelines for ...

CURB-65 and CRB-65 are simpler bedside alternatives, but they should be treated as screening tools rather than complete disposition instruments. The PSI was derived to estimate 30-day mortality across five risk classes, with mortality reported from 0.4% in class I to 31% in class V. Wolters KluwerWolters KluwerGuidelines for diagnosis and management of community- ...

Separate mortality prediction from prediction of respiratory or circulatory deterioration. SMART-COP incorporates systolic pressure, multilobar radiographic involvement, albumin, respiratory rate, tachycardia, confusion, oxygenation, and arterial pH; in one comparison it performed better than PSI and CURB-65 for predicting need for mechanical ventilation or inotropic support, although it missed some patients younger than 50 years. journal chestnetjournal chestnetProcalcitonin in Severe Community-Acquired Pneumonia - CHEST

Procalcitonin may add prognostic information in hospitalized disease: in the EPIC multicenter cohort, it was strongly associated with invasive respiratory or vasopressor support within 72 hours and correlated with ATS minor criteria, PSI, and SMART-COP severity. It should complement, not replace, bedside reassessment and organ-failure evaluation. journal chestnetjournal chestnetProcalcitonin in Severe Community-Acquired Pneumonia - CHEST

Obtain sputum and blood cultures for severe CAP and for hospitalized patients receiving empiric coverage for MRSA or Pseudomonas aeruginosa. These are the explicit high-yield testing groups identified in adult CAP guidance summaries. BMJBMJCommunity-acquired pneumonia in adults (non Covid-19) - Symptoms, diagnosis and treatment | BMJ Best Practice US

Use rapidly available molecular pathogen testing when it can clarify viral versus bacterial contributors or identify a treatable respiratory pathogen; expanded rapid molecular testing is a major feature of contemporary CAP management. NEJMNEJMUpdate on Managing Community-Acquired Pneumonia | NEJM Clinician Interpret a positive result within the clinical and imaging context rather than assuming it explains every infiltrate.

For pneumonia that does not resolve as expected or has atypical features, broaden the diagnosis before simply extending empiric antibiotics. In a recent CAP cohort, bronchoscopy was reserved for respiratory-specialist evaluation of atypical symptoms or nonresolving pneumonia, illustrating its role as a selective—not routine—diagnostic procedure. NatureNatureImpact of antibiotic changes on hospital stay and treatment duration in community-acquired pneumonia | Scientific Reports

For patients admitted with CAP, begin the first antibiotic dose while the patient remains in the emergency department after diagnostic evaluation supports pneumonia; guidance does not require a rigid four-hour deadline, reflecting the risk of misdiagnosis and antibiotic overuse when speed is prioritized over diagnostic accuracy. ccjmccjmManaging community-acquired pneumonia during flu season

Choose empiric treatment according to CAP severity, comorbidities, local resistance patterns, and whether MRSA or Pseudomonas coverage is being used; obtain cultures in the latter two scenarios to enable directed therapy and de-escalation. BMJBMJCommunity-acquired pneumonia in adults (non Covid-19) - Symptoms, diagnosis and treatment | BMJ Best Practice US Do not use this framework for hospital-acquired, ventilator-associated, COVID-19, or immunocompromised-host pneumonia without applying the relevant disease-specific guidance. NEJM+1NEJMUpdate on Managing Community-Acquired Pneumonia | NEJM Cliniciannice org ukPneumonia: diagnosis and management | Guidance

Reassess antibiotic need and regimen as pathogen data, molecular testing, oxygen requirement, hemodynamics, and radiographic-clinical concordance evolve. Contemporary CAP updates identify evidence supporting shorter antibiotic courses, making a documented clinical response and early treatment review central stewardship steps. NEJMNEJMUpdate on Managing Community-Acquired Pneumonia | NEJM Clinician

Systemic corticosteroids are an evolving issue in severe CAP: contemporary guidance updates cite new data supporting steroids specifically in severe pneumonia. Limit consideration to severe disease and verify the current guideline recommendation, contraindications, and patient-specific risks before prescribing. NEJMNEJMUpdate on Managing Community-Acquired Pneumonia | NEJM Clinician